Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.79 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.79 |
| ▸ | MAPT | P10636 | 3/20 | 0.79 |
| ▸ | PLIN1 | O60240 | 2/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.79 |
| ▸ | RECQL | P46063 | 2/20 | 0.79 |
| ▸ | PLIN5 | Q00G26 | 2/20 | 0.79 |
| ▸ | ABHD5 | Q8WTS1 | 2/20 | 0.79 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.79 |
| ▸ | F3 | P13726 | 2/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.79 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.79 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.59 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.59 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | TNKS | O95271 | 1/20 | 0.59 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chloroform SCHEMBL1367016 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL2128854 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL7629150 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL2128849 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL84057 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL2832028 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL18788602 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL28370740 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL29371090 | 1.00 | CYP1A2 (0.79) | CYP1A2CYP2C9MAPTPLIN1LMNA | |
| Chloroform SCHEMBL1043119 | 0.98 | CYP1A2 (0.83) | CYP1A2CYP2C9MAPTPLIN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021212974-A1 | RACEMIC AND CHIRAL 3-(2,3-BUTADIENYL)OXYINDOLINONE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 复旦大学 (CN) | 2021-10-28 | — | — | WO | claimed |
| CN-109369667-A | 2,3,6- tri- deoxidation glycosyl demethylated podophyllotoxin compounds and its preparation method and application | 南通大学 | 2019-02-22 | — | — | CN | claimed |
| CN-105732495-B | Tetrahydroquinolinesas with optical activation and preparation method thereof | 华中师范大学 | 2018-11-09 | — | — | CN | claimed |
| CN-105732550-B | A method of preparing chiral 3- methylene -2,3-dihydrofuran class compound | DALIAN INSTITUTE OF CHEMICAL PHYSICS, CHINESE ACADEMY OF SCIENCES (CN) | 2018-08-31 | — | — | CN | claimed |
| EP-3455224-B1 | SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-ONES AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO[2,1-C][1,2,4]TRIAZOL-3-ONES, AND USE THEREOF | BAYER AG (DE) | 2024-03-27 | — | — | EP | disclosed |
| WO-2023189861-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT, METHOD FOR PRODUCING SAME, DISPLAY DEVICE, AND LIGHTING DEVICE | 三菱ケミカル株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3269789-B1 | LIGHT EMITTING MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT | HODOGAYA CHEMICAL CO LTD (JP) | 2023-08-30 | — | — | EP | disclosed |
| WO-2022268119-A1 | SULFOXIMINE COMPOUND AND USE THEREOF | 南京明德新药研发有限公司 | 2022-12-29 | — | — | WO | disclosed |
| US-10559761-B2 | Light-emitting material, and organic electroluminescent device | KYULUX, INC. (JP) | 2020-02-11 | — | — | US | disclosed |
| CN-106415398-B | Electrophtography photosensor, electrographic cartridge, image forming apparatus and charge transport materials | 三菱化学株式会社 | 2019-11-19 | — | — | CN | disclosed |
| CN-106483779-B | Laminated electrophotographic photoreceptor, process cartridge, and image forming apparatus | 京瓷办公信息系统株式会社 | 2019-10-18 | — | — | CN | disclosed |
| CN-106854191-B | 2- 3- methylene -2,3-dihydrofuran synthetic methods containing chiral quaternary carbon center | 中国科学院大连化学物理研究所 | 2019-09-27 | — | — | CN | disclosed |
| EP-0854138-B1 | Vitamin D3 derivative and production process thereof | TEIJIN LTD (JP) | 2001-05-23 | — | — | EP | disclosed |
| US-6177586-B1 | USEFUL AS A PHARMACEUTICAL SUCH AS AN AGENT FOR PROMOTING BONE FORMATION, AN AGENT FOR SUPPRESSING PROLIFERATION OF TUMOR CELLS, AN AGENT FOR HIGH CALCIUM BLOOD DISEASES, AND AN IMMUNOSUPPRESSION AGENT | TEIJIN LIMITED (JP) | 2001-01-23 | — | — | US | disclosed |
| EP-0712843-B1 | VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | TEIJIN LTD (JP) | 1999-11-17 | — | — | EP | disclosed |
| US-5986112-A | STEROID DERIVATIVES AS ANTITUMOR AGENTS AND BLOOD METAL CONCENTRATES | TEIJIN LIMITED (JP) | 1999-11-16 | — | — | US | disclosed |
| EP-0854139-A2 | Vitamin D3 derivative and production process thereof | TEIJIN LIMITED (JP) | 1998-07-22 | — | — | EP | disclosed |
| EP-0854138-A2 | Vitamin D3 derivative and production process thereof | TEIJIN LIMITED (JP) | 1998-07-22 | — | — | EP | disclosed |
| US-5719297-A | Vitamin D3 derivatives and production process thereof | TEIJIN LIMITED (JP) | 1998-02-17 | — | — | US | disclosed |
| EP-0712843-A1 | VITAMIN D3 DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | TEIJIN LIMITED (JP) | 1996-05-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10559761-B2 | Light-emitting material, and organic electroluminescent device | EML4, L1CAM, CRY1 | CYP1A2 477/4885CYP2C9 166/4885MAPT 1622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.